IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q2 2020 Holdings

Filed 2020-08-14 | 15 holdings | $8.1M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2020-08-14) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cardiff Oncology Inc(CRDF)ACOM14147L108$8.0M1,595,16498.9%
Molecular Templates IncCOM608550109$29.1K2,107,9910.4%
Strongbridge Biopharma PLCSHS USDG85347105$25.0K6,612,0650.3%
Sierra Oncology IncCOM NEW82640U404$7.8K643,9590.1%
Kala Pharmaceuticals IncCOM483119103$6.5K620,2890.1%
Scynexis IncCOM811292101$6.0K7,946,1110.1%
Garrison Cap Inc(GARSUSD)COM366554103$3.9K1,164,0610.0%
Spdr Gold TR(GLD)GOLD SHS78463V107$2.7K15,9230.0%
Satsuma Pharmaceuticals IncCOM80405P107$2.0K68,1720.0%
MEI Pharma IncCOM NEW55279B202$1.2K295,5600.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$78781,9830.0%
CTI Biopharma Corp(CTIC1USD)COM12648L601$719619,4600.0%
Iveric BIO Inc(OPHTEUR)COM46583P102$636124,7710.0%
Kura Oncology Inc(KURA)COM50127T109$33320,4060.0%
Addex Therapeutics LTD(ADXNUSD)SPONSORED ADS00654J107$15217,4180.0%